Neuroprotective Effects of Some Plant Extracts Against Dopamine-induced Oxidative Stress on Neuronal Cell |
Koo, Uk
(Natural Product Research Institute, College of Pharmacy, Seoul National University)
Lee, Hak-Ju (Korea Forest Research Institute) Lee, Dong-Ho (College of Life sciences & Biotechnology, Korea University) Lee, Hyun-Jung (Korea Forest Research Institute) Ham, Ah-Rom (Natural Product Research Institute, College of Pharmacy, Seoul National University) Mar, Woong-Chon (Natural Product Research Institute, College of Pharmacy, Seoul National University) |
1 | Ben-Shachar, D., Zuk, R. and Glinka, Y. (1995) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 64: 718-723 DOI PUBMED |
2 | Cavalieri, E. L., Li, K. M., Balu, N., Saeed, M., Devanesan, P., Higginbotham, S., Zhao, J., Gross, M. L. and Rogan, E. G. (2002) Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23: 1071-1077 DOI ScienceOn |
3 | Xu, Y., Stokes, A. H., Roskoski, R., Jr. and Vrana, K. E. (1998) Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase. J Neurosci Res 54: 691-697 DOI ScienceOn |
4 | Castaigne, P., Laplane, D. and Dordain, G. (1971) Clinical experimentation with apomorphine in Parkinson's disease. Res Commun Chem Pathol Pharmacol 2: 154-158 PUBMED |
5 | Sung, S. H., Kim, E. S., Lee, K. Y., Lee, M. K. and Kim, Y. C. (2006) A new neuroprotective compound of Ligustrum japonicum leaves. Planta Med 72: 62-64 DOI ScienceOn |
6 | Jin, F., Wu, Q., Lu, Y. F., Gong, Q. H. and Shi, J. S. (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600: 78-82 DOI PUBMED ScienceOn |
7 | Stokes, A. H., Hastings, T. G. and Vrana, K. E. (1999) Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55: 659-665 DOI ScienceOn |
8 | Cho, J., Joo, N. E., Kong, J. Y., Jeong, D. Y., Lee, K. D. and Kang, B. S. (2000) Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons. J Ethnopharmacol 73: 31-37 DOI ScienceOn |
9 | Turjanski, N. and Lees, A. J. (1990) Apomorphine in the treatment of Parkinson's disease. Medicina (B Aires) 50: 365-368 PUBMED ScienceOn |
10 | Silvestrin, R. B., de Oliveira, L. F., Batassini, C., Oliveira, A. and E. Souza TM (2008) The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease. J Neurosci Methods DOI ScienceOn |
11 | Poewe, W., Kleedorfer, B., Gerstenbrand, F. and Oertel, W. (1988) Subcutaneous apomorphine in Parkinson's disease. Lancet 1: 943 DOI PUBMED ScienceOn |
12 | Junn, E. and Mouradian, M. M. (2001) Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 78: 374-383 DOI ScienceOn |
13 | Sulzer, D. and Zecca, L. (2000) Intraneuronal dopaminequinone synthesis: a review. Neurotox Res 1: 181-195 DOI ScienceOn |
14 | Deffond, D., Durif, F. and Tournilhac, M. (1993) Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes. J Neurol Neurosurg Psychiatry 56: 101-103 DOI PUBMED |
15 | Cho, J., Kong, J. Y., Jeong, D. Y., Lee, K. D., Lee, D. U. and Kang, B. S. (2001) NMDA recepter-mediated neuroprotection by essential oils from the rhizomes of Acorus gramineus. Life Sci 68: 1567-1573 DOI ScienceOn |
16 | Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J., Miyoshi, K., Ogawa, N. and Murata, M. (2008) Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation. Neurosci Res 60: 106-113 DOI ScienceOn |
17 | Smythies, J. and Galzigna, L. (1998) The oxidative metabolism of catecholamines in the brain: a review. Biochim Biophys Acta 1380: 159-162 DOI PUBMED ScienceOn |
18 | Morris, J. K., Zhang, H., Gupte, A. A., Bomhoff, G. L., Stanford, J. A. and Geiger, P. C. (2008) Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease. Brain Res 1240: 185-195 DOI PUBMED ScienceOn |
19 | Tao, G., Irie, Y., Li, D. J. and Keung, W. M. (2005) Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity. Bioorg Med Chem 13: 4777-4788 DOI ScienceOn |